Prognostic value of circulating tumor cells' reduction in patients with extensive small-cell lung cancer

Lung Cancer

Volumn 85, Issue 2, 2014, Pages 314-319

  Normanno, Nicola ^a   Rossi, Antonio ^b   Morabito, Alessandro ^a   Signoriello, Simona ^c   Bevilacqua, Simona ^a   Di Maio, Massimo ^a   Costanzo, Raffaele ^a   De Luca, Antonella ^a   Montanino, Agnese ^a   Gridelli, Cesare ^b   Rocco, Gaetano ^a   Perrone, Francesco ^a   Gallo, Ciro ^c  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b S G MOSCATI HOSPITAL   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Chemotherapy; Circulating tumor cells; Extensive stage; Prognosis; Small cell lung cancer; Validation

Indexed keywords

CARBOPLATIN; CISPLATIN DERIVATIVE; ETOPOSIDE;

ACCURACY; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CIRCULATING TUMOR CELL; COHORT ANALYSIS; CONTROLLED STUDY; EXTENSIVE SMALL CELL LUNG CANCER; FEMALE; FOLLOW UP; HARRELL C INDEX; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT ASSESSMENT; PRIORITY JOURNAL; CANCER STAGING; CELL COUNT; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; REPRODUCIBILITY; SMALL CELL LUNG CARCINOMA; TUMOR EMBOLISM; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CELL COUNT; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SMALL CELL LUNG CARCINOMA;

EID: 84904115982     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2014.05.002     Document Type: Article

References (24)

1. Jackman D.M., Johnson B.E. Small-cell lung cancer. Lancet 2005, 366:1385-1396.
2. Wheatley-Price P., Ma C., Ashcroft L.F., Nankivell M., Stephens R.J., White S.C., et al. The strength of female sex as a prognostic factor in small-cell lung cancer: a pooled analysis of chemotherapy trials from the Manchester Lung Group and Medical Research Council Clinical Trials Unit. Ann Oncol 2010, 21:232-237.
3. Pantel K., Brakenhoff R.H., Brandt B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 2008, 8:329-340.
4. Mego M., Mani S.A., Cristofanilli M. Molecular mechanisms of metastasis in breast cancer - clinical applications. Nat Rev Clin Oncol 2010, 7:693-701.
5. Budd G.T., Cristofanilli M., Ellis M.J., Stopeck A., Borden E., Miller M.C., et al. Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer. Clin Cancer Res 2006, 12:6403-6409.
6. Cristofanilli M., Budd G.T., Ellis M.J., Stopeck A., Matera J., Miller M.C., et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004, 351:781-791.
7. Cristofanilli M., Hayes D.F., Budd G.T., Ellis M.J., Stopeck A., Reuben J.M., et al. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 2005, 23:1420-1430.
8. Danila D.C., Heller G., Gignac G.A., Gonzalez-Espinoza R., Anand A., Tanaka E., et al. Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. Clin Cancer Res 2007, 13:7053-7058.
9. Cohen S.J., Punt C.J., Iannotti N., Saidman B.H., Sabbath K.D., Gabrail N.Y., et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 2008, 26:3213-3221.
10. de Bono J.S., Scher H.I., Montgomery R.B., Parker C., Miller M.C., Tissing H., et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res 2008, 14:6302-6309.
11. Krebs M.G., Sloane R., Priest L., Lancashire L., Hou J.M., Greystoke A., et al. Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. J Clin Oncol 2011, 29:1556-1563.
12. Bevilacqua S., Gallo M., Franco R., Rossi A., De Luca A., Rocco G., et al. A "live" biopsy in a small-cell lung cancer patient by detection of circulating tumor cells. Lung Cancer 2009, 65:123-125.
13. Hou J.M., Krebs M.G., Lancashire L., Sloane R., Backen A., Swain R.K., et al. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. J Clin Oncol 2012, 30:525-532.
14. Naito T., Tanaka F., Ono A., Yoneda K., Takahashi T., Murakami H., et al. Prognostic impact of circulating tumor cells in patients with small cell lung cancer. J Thorac Oncol 2012, 7:512-519.
15. Hiltermann T.J., Pore M.M., van den Berg A., Timens W., Boezen H.M., Liesker J.J., et al. Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor. Ann Oncol 2012, 23:2937-2942.
16. Riethdorf S., Fritsche H., Muller V., Rau T., Schindlbeck C., Rack B., et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res 2007, 13:920-928.
17. Harrell F.E., Lee K.L., Mark D.B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996, 15:361-387.
18. Efron B., Tibshirani R. An introduction to the bootstrap 1993, Chapman and Hall, New York, NY.
19. Altman D.G., Lausen B., Sauerbrei W., Schumacher M. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 1994, 86:829-835.
20. Justice A.C., Covinsky K.E., Berlin J.A. Assessing the generalizability of prognostic information. Ann Intern Med 1999, 130:515-524.
21. Pepe M.S., Feng Z., Huang Y., Longton G., Prentice R., Thompson I.M., et al. Integrating the predictiveness of a marker with its performance as a classifier. Am J Epidemiol 2008, 167:362-368.
22. Vickers A.J., Jang K., Sargent D., Lilja H., Kattan M.W. Systematic review of statistical methods used in molecular marker studies in cancer. Cancer 2008, 112:1862-1868.
23. Kattan M.W. Evaluating a new marker's predictive contribution. Clin Cancer Res 2004, 10:822-824.
24. Harrell F.E., Lee K.L., Matchar D.B., Reichert T.A. Regression models for prognostic prediction: advantages, problems, and suggested solutions. Cancer Treat Rep 1985, 69:1071-1077.